Aging is a natural process concerning physiological, cellular, psychological, social changes of an organism over a period. It is not just restricted to a single region rather affecting the whole world. By 2050, the world's population aged 60 years and older is expected to reach 2 billion, up from 900 million in 2015. Currently, 125 million people are aged 80 years or above. Countries like India where the population pyramid was of expanding type will soon show a change due to the aging and increased life expectancy. It leads to the onset of several eye defects. Some of the eye defects are hereditary such as aniridia. It is a congenital, hereditary, bilateral, extreme form of iris hypoplasia that may be associated with other ocular defects. It describes an extreme form of iris hypoplasia in which the iris appears absent on superficial clinical examination. However, gonioscopy shows the presence of the iris root. Aniridia is not just an isolated defect in iris development but is a panocular disorder with macular and optic nerve hypoplasia, cataract, and corneal changes that are other anomalies that lead to decreased vision and nystagmus. Other conditions that lead to the disruption of iris include Iris hypoplasia, Congenital mydriasis and Iris coloboma. advent of artificial iris lead to the therapeutic treatment of this condition. Artificial iris derived a revenue of US$ 10.61 Million in 2018 and is expected to fetch US$ 16.28 Million by 2025 displaying tremendous CAGR of 6.39% over the forecast period (2019-2025).
The global artificial iris market is segmented based on material type (Fiber and Fiber Free), Age group (Pediatric and Adult Cohorts), colour (blue, brown and other colour), application (cosmetic and therapeutic) and end-users (hospitals, eye surgery centers and other end user) are the major focus areas considered while analyzing and defining the penetration of artificial iris at global scale. Under the material type segment, in 2018, the fibre-free dominated the global artificial iris market with the maximum share in terms of revenue. Based on estimation, the segment occupied 55.3% share in 2018. Adult Cohorts dominated the age group segment. Amongst the colour segment blue colour dominated the market with a revenue of US$ 4.75 million in 2018, followed by brown. Therapeutics is the application of the artificial iris and is utilized by the patients suffering from major iris defects. Hospital is the major institution where patients undergo this procedure of artificial iris implantation. Also, for better understanding of the overall adoption rate of artificial iris in different market, detailed analysis has been done for different regions/countries including North America (US, Rest of the North America), Europe (Germany, Netherlands and Rest of the Europe), Asia Pacific (China, India, Japan and Rest of the APAC), and the rest of the world (Middle East and Latin America). Based on the estimation, Europe dominated the global artificial iris market, accounting for revenue share of 41.2% in 2018. On account of the strong presence of major market players.
Numerous companies have earmarked their presence in the global artificial iris market with continued focus on product expansions, investments, business expansion, product launches and collaborations. Some of the major players operating in the global artificial iris market include Ophtec, HumanOptics AG, Morcher, ReperNN, VEO Ophthalmics, Spectrum Surgical, Eye-yon Medical and Pixium vision.
Global artificial iris market generated revenue of US$ 10.61 million in 2018. The technology is expected to grow at a CAGR of 6.39% during the forecast period to reach a market valuation of US$ 16.28 million by 2025. Europe dominated the global artificial iris, accounting for revenue share of 41.2% in 2018.
Global Artificial Iris Market was valued at US$ 10.61 million in 2018 and is anticipated to reach US$ 16.28 million by 2025 displaying reasonable CAGR of 6.39% over the forecast period (2019-2025). Artificial iris is a prosthetic iris that is primarily utilized in the process of replacing the damaged iris in several eye defects as such congenital aniridia and traumatic iris loss and other eye complications. The FDA approved the first artificial iris implant for patients with congenital aniridia (absence of an iris) or eye damage, called the CustomFlex from HumanOptics AG, a German firm. An artificial iris is implanted when a surgeon makes a small incision and implants it. This Iris is held in place by the anatomical structures of the eye or, if needed, by sutures, and mimics the function of the natural iris. It creates an artificial pupil that reduces the amount of light entering the eye. The surgically implanted prosthetic is made of thin, foldable silicone and is sized and coloured for individual patients, according to the agency. It was shown to be safe and effective in a clinical trial of 389 adults and children with aniridia or other iris defects. The major drivers that will influence the adoption of artificial iris include a growing number of eye defects, escalating geriatric population and eye defects associated with aging and increasing demand for minimally invasive surgical procedures. However, lack of reimbursement will act as a restraint. Moreover, the advent of artificial intelligence will act as an opportunity.
"Amongst material type, Fibre-free artificial iris dominated the global market in 2018, accounting for 55.4% share"
Based on material type, the market has been divided into fibre and fibre free. In 2018, Fibre-free artificial iris dominated the market. Fibre model is composed of an embedded polyester meshwork layer to provide ample tear strength to withstand suturing whereas, the fibre-free model is suitable for sutureless implant techniques or can be sutured. Fibre artificial iris is expected to witness a CAGR growth of 7.01% during the analysed period.
"Adult cohorts are expected to dominate the age group during the forecast period 2019-2025"
In terms of the patient's age, the market is divided into Paediatrics and adult cohorts. Paediatrics suffering from congenital aniridia can undergo the procedure for the correction of inborn disorder. In 2018, artificial iris implant was majorly performed on adults, which accounted for more than 90% of cases.
"Artificial Iris was majorly applied for Therapeutics application, followed by Cosmetic application"
Based on application, the market has been bifurcated into cosmetic and therapeutic. Cosmetic applications are for the patients who are self-conscious about the appearance of their eyes with an abnormal pupil. Therapeutic application of the artificial iris is for the patient suffering from traumatic iris defects. In 2018, Cosmetic application segment generated revenue of US$ 2.12 million. However, the Therapeutics application segment is expected to witness a CAGR growth of 6.28% during the analysed period.
"Blue colour iris dominated the market, followed by brown colour in 2018"
Based on colour, the global artificial iris market is bifurcated into brown iris and blue iris and other colour artificial iris. Blue colour dominated the market as it is highly preferred by the patients when undergone cosmetic surgery for the changing of eye colour. The brown colour artificial iris segment is expected to generate revenue of US$ 5.65 million by 2025.
"Amongst end-user, the hospital segment dominated the market in 2018, and is anticipated to dominate Global Artificial Iris market by 2025."
Based on end-user, the global artificial iris market is segmented into hospitals, eye surgery centres and other end-user. Hospital segment dominated the market as it is one of the major institutions that offer healthcare services such as surgeries and prosthetic implantations. The segment is expected to witness a CAGR growth of 6.1% during the forecast period 2019-2025.
"In 2018, Europe was the largest market for Artificial Iris technology"
For a deep-dive analysis of the overall adoption and penetration of Artificial iris technology, detailed region/country level study was conducted for major region/county including North America (US, Canada, Rest of North America), Europe (Germany, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India and Rest of Asia-Pacific) and Rest of the World. In 2018, Europe represented as the highest revenue-generating region, accounting for 41% share, followed by North America and Asia-Pacific. Asia-Pacific is expected to witness a CAGR growth of 6.96% during the analyzed period 2019-2025.
Competitive Landscape-Top Market Players
Ophtec, HumanOptics AG, Morcher, ReperNN, VEO Ophthalmics, Spectrum Surgical, Eye-yon Medical and Pixium Vision are some of the prominent players operating in the Global Artificial Iris market. Several product launches, M&A's along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Reasons to buy:
? Current and future market size from 2018 to 2025 in terms of value (US$)
? Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
? Country-level details of the overall adoption of Artificial Iris market
? A quick review of overall industry performance at a glance
? In-depth analysis of key industry players
? The current and projected scenario of the world's eyesight, techniques for artificial iris implantation and pipeline activity of devices
? A detailed analysis of drivers, restraints, key trends and opportunities prevailing in the industry
? Examination of industry attractiveness with the help of Porter's Five Forces analysis and start-ups
? The study comprehensively covers the market across different segments and sub-segments of the technology
? Region/country Covered: North America (US, Canada, Rest of North America), Europe (Germany, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India and Rest of Asia-Pacific) and Rest of the World
Customization Options:
UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Artificial Iris Market can be customized to the country level or any other market segment.
Table of Contents
1. MARKET INTRODUCTION
1.1 Market Definition 16
1.2 Objective of the Study 16
1.3 Limitation 16
1.4 Stakeholders 16
1.5 Currency used in the Report 17
1.6 Scope of the Global Artificial Iris Market Study 17
2. RESEARCH METHODOLOGY OR ASSUMPTION 18
2.1 Research Methodology for Global Artificial Iris Market Study 18
2.1.1 Main objective of the Artificial Iris Market Study 19
3. INDUSTRY PERFORMANCE 20
4. EXECUTIVE SUMMARY 22
5. CURRENT AND PROJECTED SCENARIO OF THE WORLD'S EYESIGHT 24
5.1 General Overview 24
5.1.1 Key Facts on the state of the world's eyesight 24
5.1.2 Improving the world's Eyesight; the Goals of Vision 2020 28
6. MARKET OVERVIEW 30
6.1 Introduction 30
6.2 Market Dynamics 31
6.2.1 Market Drivers 31
6.2.1.1 Accelerating Geriatric Population 31
6.2.1.1.1 Some of the Key Facts regarding Ageing and health 31
6.2.1.2 Growing Number of Eye Defects 33
6.2.1.3 Increasing Demand of Minimally Invasive Surgical Procedures 34
6.2.1.4 Rising Healthcare Expenditure and Health-Conscious Personals 34
6.2.2 Market Restraints 38
6.2.2.1 Side Effects Associated with Implant Procedure 38
6.2.2.2 Lack of Reimbursement 38
6.2.2.3 Lack of Trained Professionals 39
6.2.3 Market Opportunities 39
6.2.3.1 Artificial Intelligence (AI) in Ophthalmology 39
7. TECHNIQUES FOR ARTIFICIAL IRIS IMPLANTATION 41
7.1 Overview 41
7.1.1 Surgical Techniques 41
7.1.2 Techniques 42
7.1.3 Sector- or Segment-Shaped Artificial Iris Sutured Side-by-Side to the Residual Iris 43
7.1.4 Injector-Assisted Sulcus-Fixated Complete Iris in Pseudophakic Eyes 43
7.1.5 Injector-Assisted Implantation of a Complete Iris in the Capsular Bag in Combination with Planned Standard Cataract Surgery 43
7.1.6 Complete Iris Prosthesis Implantation Sutured to the Sclera in Combination with a Scleral-Fixated Intraocular Lens in Aniridia and Aphakia of Vitrectomized Eyes 44
7.1.7 "Sandwich" or "Backpack" Iris Prosthesis Implantation in Combination with an Intraocular Lens in Aniridia and Aphakia 44
7.1.8 Open-Sky Implantation During a Perforating Keratoplasty 45
8. DEMAND AND SUPPLY SIDE ANALYSIS 46
8.1 Demand Side Analysis 46
8.2 Supply Side Analysis 47
8.2.1 Top Product Launch 48
8.2.2 Top Partnerships 48
8.2.3 Top Business Expansion & Investment 48
8.2.4 Value Chain Analysis of Artificial Iris 49
9. PIPELINE ACTIVITY 50
9.1 EndoArt Artificial Endothelial Layer: Eye-yon Medical 50
9.1.1 Product Description 50
9.1.2 Research and Development 50
9.2 Retinal Implant System (IRIS): Intelligent Medical Implants 51
9.2.1 Product Description 51
9.2.2 Research and Development 51
10. MARKET INSIGHTS BY MATERIAL TYPE 52
10.1 General Overview 52
10.1.1 Fiber Artificial Iris 54
10.1.1.1 Case Study: Comparison of complication rate for artificial iris with or without mesh 55
10.1.2 Fiber-free Artificial Iris 56
11. MARKET INSIGHTS BY COLOUR 58
11.1 General Overview 58
11.1.1 Blue Colour Artificial Iris 60
11.1.2 Brown Colour Artificial Iris 61
11.1.3 Other Colour Artificial Iris 61
12. MARKET INSIGHTS BY APPLICATION 63
12.1 General Overview 63
12.1.1 Cosmetic Application 64
12.1.2 Therapeutic Application 65
13. MARKET INSIGHTS BY AGE GROUP 67
13.1 General Overview 67
13.1.1 Pediatric 68
13.1.2 Adults 71
14. MARKET INSIGHTS BY END-USERS 73
14.1 General Overview 73
14.1.1 Hospitals 74
14.1.2 Eye Surgery Centers 75
14.1.3 Others Eye Care Facility 77
15. MARKET INSIGHTS BY REGION 78
15.1 General Overview 78
15.2 North America Artificial Iris Market (2018-2025) 80
15.2.1 North America Artificial Iris Market by Material Type 80
15.2.2 North America Artificial Iris Market by Colour 81
15.2.3 North America Artificial Iris Market by Application 81
15.2.4 North America Artificial Iris Market by Age Group 82
15.2.5 North America Artificial Iris Market by End-User 82
15.2.6 North America Artificial Iris Market by Country 83
15.2.6.1 United States Artificial Iris Market (2018-2025) 83
15.2.6.1.1 Eye Health Statistics, US 84
15.2.6.1.2 US Health Spending by Type of Service or Product, 2017 85
15.2.6.1.3 Health Spending by Major Sources of Funds 87
15.2.6.1.4 US Artificial Iris Market by Material Type 88
15.2.6.1.5 US Artificial Iris Market by Colour 88
15.2.6.1.6 US Artificial Iris Market by Application 89
15.2.6.1.7 US Artificial Iris Market by Age Group 89
15.2.6.1.8 US Artificial Iris Market by End-User 90
15.2.6.2 Canada Artificial Iris Market (2018-2025) 90
15.2.6.2.1 The Prevalence of Canadian Vision Loss and Cataract Surgery 90
15.2.6.2.2 Key Findings on Canada Healthcare Spending, 2018 92
15.2.6.2.3 Key Findings on Hospital sector Spending in Canada, 2017 93
15.2.6.2.4 Canadian Population Projection 94
15.2.6.2.5 Canada Artificial Iris Market by Material Type 94
15.2.6.2.6 Canada Artificial Iris Market by Colour 95
15.2.6.2.7 Canada Artificial Iris Market by Application 95
15.2.6.2.8 Canada Artificial Iris Market by Age Group 96
15.2.6.2.9 Canada Artificial Iris Market by End-User 96
15.2.6.3 Rest of North America Artificial Iris market (2018-2025) 97
15.2.6.3.1 Rest of North America Artificial Iris Market by Material Type 98
15.2.6.3.2 Rest of North America Artificial Iris Market by Colour 99
15.2.6.3.3 Rest of North America Artificial Iris Market by Application 99
15.2.6.3.4 Rest of North America Artificial Iris Market by Age Group 100
15.2.6.3.5 Rest of North America Artificial Iris Market by End-User 100
15.3 Europe Artificial Iris Market (2018-2025) 101
15.3.1 Europe Artificial Iris Market by Material Type 101
15.3.2 Europe Artificial Iris Market by Colour 102
15.3.3 Europe Artificial Iris Market by Application 102
15.3.4 Europe Artificial Iris Market by Age Group 103
15.3.5 Europe Artificial Iris Market by End-User 103
15.3.6 Europe Artificial Iris Market by Country 104
15.3.6.1 Germany Artificial Iris Market (2018-2025) 104
15.3.6.1.1 Germany Artificial Iris Market by Material Type 105
15.3.6.1.2 Germany Artificial Iris Market by Colour 106
15.3.6.1.3 Germany Artificial Iris Market by Application 106
15.3.6.1.4 Germany Artificial Iris Market by Age Group 107
15.3.6.1.5 Germany Artificial Iris Market by End-User 107
15.3.6.2 Netherlands Artificial Iris Market (2018-2025) 108
15.3.6.2.1 Netherlands Artificial Iris Market by Material Type 108
15.3.6.2.2 Netherlands Artificial Iris Market by Colour 109
15.3.6.2.3 Netherlands Artificial Iris Market by Application 109
15.3.6.2.4 Netherlands Artificial Iris Market by Age Group 110
15.3.6.2.5 Netherlands Artificial Iris Market by End-User 110
15.3.6.3 Rest of Europe Artificial Iris Market (2018-2025) 111
15.3.6.3.1 Rest of Europe Artificial Iris Market by Material Type 111
15.3.6.3.2 Rest of Europe Artificial Iris Market by Colour 111
15.3.6.3.3 Rest of Europe Artificial Iris Market by Application 112
15.3.6.3.4 Rest of Europe Artificial Iris Market by Age Group 112
15.3.6.3.5 Rest of Europe Artificial Iris Market by End-User 113
15.4 Asia Pacific Artificial Iris Market (2018-2025) 113
15.4.1 Asia-Pacific Artificial Iris Market by Material Type 115
15.4.2 Asia-Pacific Artificial Iris Market by Colour 115
15.4.3 Asia-Pacific Artificial Iris Market by Application 116
15.4.4 Asia-Pacific Artificial Iris Market by Age Group 116
15.4.5 Asia-Pacific Artificial Iris Market by End-User 117
15.4.6 Asia Pacific Artificial Iris Market by Country 117
15.4.6.1 Japan Artificial Iris Market (2018-2025) 118
15.4.6.1.1 Japan Artificial Iris Market by Material Type 119
15.4.6.1.2 Japan Artificial Iris Market by Colour 119
15.4.6.1.3 Japan Artificial Iris Market by Application 120
15.4.6.1.4 Japan Artificial Iris Market by Age Group 120
15.4.6.1.5 Japan Artificial Iris Market by End-User 121
15.4.6.2 China Artificial Iris Market (2018-2025) 121
15.4.6.2.1 China Artificial Iris Market by Material Type 122
15.4.6.2.2 China Artificial Iris Market by Colour 123
15.4.6.2.3 China Artificial Iris Market by Application 123
15.4.6.2.4 China Artificial Iris Market by Age Group 124
15.4.6.2.5 U China S Artificial Iris Market by End-User 124
15.4.6.3 India Artificial Iris Market (2018-2025) 125
15.4.6.3.1 India Artificial Iris Market by Material Type 125
15.4.6.3.2 India Artificial Iris Market by Colour 126
15.4.6.3.3 India Artificial Iris Market by Application 126
15.4.6.3.4 India Artificial Iris Market by Age Group 127
15.4.6.3.5 India Artificial Iris Market by End-User 127
15.4.6.4 Rest of APAC Artificial Iris Market (2018-2025) 128
15.4.6.4.1 Rest of APAC Artificial Iris Market by Material Type 129
15.4.6.4.2 Rest of APAC Artificial Iris Market by Colour 130
15.4.6.4.3 Rest of APAC Artificial Iris Market by Application 130
15.4.6.4.4 Rest of APAC Artificial Iris Market by Age Group 131
15.4.6.4.5 Rest of APAC Artificial Iris Market by End-User 131
15.5 Rest of World Artificial Iris Market (2018-2025) 132
15.5.1 ROW Artificial Iris Market by Material Type 133
15.5.2 ROW Artificial Iris Market by Colour 134
15.5.3 ROW Artificial Iris Market by Application 134
15.5.4 ROW Artificial Iris Market by Age Group 135
15.5.5 ROW Artificial Iris Market by End-User 135
16. COMPETITIVE SCENARIO 136
16.1 Porter's Five forces analysis 136
16.1.1 Bargaining power of Supplier 137
16.1.2 Bargaining power of Buyer 137
16.1.3 Industry Rivalry 137
16.1.4 Availability of Substitute 137
16.1.5 Threat of new Entrants 138
17. TOP COMPANY PROFILES 139
17.1 Morcher 139
17.1.1 Key Facts 139
17.1.2 Business Description 139
17.1.3 Key Product/Services Offerings 139
17.1.4 Growth Strategy 142
17.2 Ophtec 144
17.2.1 Key Facts 144
17.2.2 Business Description 144
17.2.3 Key Product/Services Offerings 145
17.2.4 Growth Strategy 147
17.2.5 SWOT Analysis 147
17.2.6 Recent Developments 148
17.2.6.1 Partnerships (Strategic Alliance) 148
17.2.6.2 Business Expansion 148
17.3 HumanOptics 149
17.3.1 Key Facts 149
17.3.2 Business Description 149
17.3.3 Key Product/Services Offerings 149
17.3.4 Growth Strategy 150
17.3.5 SWOT Analysis 150
17.4 Reper NN 151
17.4.1 Key Facts 151
17.4.2 Business Description 151
17.4.3 Key Product/Services Offerings 151
17.5 VEO Ophthalmics 152
17.5.1 Key Facts 152
17.5.2 Business Description 152
17.5.3 Key Product/Services Offerings 152
17.5.4 Recent Developments 153
17.5.4.1 Product Launches 153
17.5.4.2 Partnership 153
17.6 Spectrum Surgical 154
17.6.1 Key Facts 154
17.6.2 Business Description 154
17.6.3 Key Product/Services Offerings 155
17.6.4 Growth Strategy 156
17.7 EyeYon Medical 157
17.7.1 Key Facts 157
17.7.2 Business Description 157
17.7.3 Key Product/Services Offerings 157
17.7.4 Growth Strategy 157
17.8 Pixium Vision 159
17.8.1 Key Facts 159
17.8.2 Business Description 160
17.8.3 Key Product/Services Offerings 160
17.8.4 Growth Strategy 160
17.8.5 SWOT Analysis 162
17.8.6 Key Financials 163
17.8.7 Recent Developments 164
17.8.7.1 Product Launches 164
List of Figures
FIG. 1 Scope of the Global Artificial Iris Market Study 16
FIG. 2 Research Methodology for Global Artificial Iris Market Study 17
FIG. 3 Global Artificial Iris Market by Value, 2018-2025 (US$ Billion) 22
FIG. 4 Key Facts on Most Affected Peoples 24
FIG. 5 Leading Causes of Blindness, Globally 25
FIG. 6 Neglected Tropical Diseases, Africa 25
FIG. 7 Cataract the Leading Cause of Blindness in Developing Countries 26
FIG. 8 Lack of Qualified Professional a major Challenge 27
FIG. 9 Number of Persons aged 65+ years by Geographic Region, 2019 and 2050 (in Millions) 30
FIG. 10 Number of People aged 65 or older per 100 people of working age (15-64), by Region 31
FIG. 11 Ten countries or areas with the highest old-age dependency ratio (65+/20-64), 2019 and 2050 31
FIG. 12 Current expenditure on health, % of GDP (2018) 35
FIG. 13 Current Expenditure on Health, Per Capita, US$ PPP (2017) 36
FIG. 14 Limitations of Artificial Iris Implantaion 37
FIG. 15 Simplified Structure of an Artificial Neural Network 39
FIG. 16 Process to Undergo Artificial Iris Implantation 41
FIG. 17 Countries or areas with the largest share of persons aged 60 years or over (2017, 2050) (%) 45
FIG. 18 Artificial Iris Value Chain 48
FIG. 19 CustomFlex Artificial Iris with Fiber and Fiber-Free Models 52
FIG. 20 Global Artificial Iris Market Share, by Material Type, 2018 & 2025 (%) 52
FIG. 21 Global Artificial Iris Market Size, by Material Type, 2018-25 (US$ Mn) 53
FIG. 22 Global Fiber Based Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 54
FIG. 23 Global Fiber Free Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 56
FIG. 24 Eye Colour & Estimated Percentage of World Population 57
FIG. 25 Global Artificial Iris Market Share, by Colour, 2018 & 2025 (%) 58
FIG. 26 Global Artificial Iris Market Size, by Colour, 2018-25 (US$ Mn) 59
FIG. 27 Global Blue Colour Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 59
FIG. 28 Global Brown Colour Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 60
FIG. 29 Global Artificial Iris Others Market Size, by Region, 2018-25 (US$ Mn) 61
FIG. 30 Global Artificial Iris Market Share, by Application, 2018 & 2025 (%) 62
FIG. 31 Global Artificial Iris Market Size, by Application, 2018-25 (US$ Mn) 63
FIG. 32 Global Artificial Iris Cosmetic Application Market Size, by Region, 2018-25 (US$ Mn) 64
FIG. 33 Global Artificial Iris Therapeutic Application Market Size, by Region, 2018-25 (US$ Mn) 65
FIG. 34 Global Artificial Iris Market Share, by Age Group, 2018 & 2025 (%) 66
FIG. 35 Global Artificial Iris Market Share, by Age Group, 2018-25 (US$ Mn) 67
FIG. 36 Proportion of Selected Age Groups of World Population in 2019, by Region 68
FIG. 37 Global Pediatric Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 70
FIG. 38 Global Artificial Iris Adults Market Size, by Region, 2018-25 (US$ Mn) 71
FIG. 39 Global Artificial Iris Market Share, by End User, 2018 & 2025 (%) 72
FIG. 40 Global Artificial Iris Market Size, by End User, 2018-25 (US$ Mn) 72
FIG. 41 Artificial Iris Implant in 8 Alymed accredited Hospitals 73
FIG. 42 Global Hospital Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 74
FIG. 43 Number of Eye Surgery Centres in the United States 75
FIG. 44 Global Eye Surgery Centres Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 75
FIG. 45 Global Other Eye Care Facility Artificial Iris Market Size, by Region, 2018-25 (US$ Mn) 76
FIG. 46 Overall Global Tourism, 2017 77
FIG. 47 Global Artificial Iris Market Share by Region, 2018 & 2025 (%) 78
FIG. 48 Global Artificial Iris Market Size by Region, 2019-25 (US$ Billion) 78
FIG. 49 North America Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 79
FIG. 50 North America Artificial Iris Market by Colour, 2018- 2025 (US$ Billion) 80
FIG. 51 North America Artificial Iris Market by Application, 2018- 2025 (US$ Billion) 80
FIG. 52 North America Artificial Iris Market by Age Group, 2018- 2025 (US$ Billion) 81
FIG. 53 North America Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 81
FIG. 54 North America Artificial Iris Market by Country, 2018-2025 (US$ Billion) 82
FIG. 55 Number of Eye Surgery Centres in the United States 83
FIG. 56 Growing American Aging Population in 2020 & 2050 (in million) 84
FIG. 57 US Health Spending by Type of Service or Product, 2017 86
FIG. 58 US Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 87
FIG. 59 US Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 87
FIG. 60 US Artificial Iris Market by Application, 2018-2025 (US$ Billion) 88
FIG. 61 US Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 88
FIG. 62 US Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 89
FIG. 63 Percentage by Ophthalmology main work setting in Canada, 2017 91
FIG. 64 Canada Health Spending by Sources of Funds, 2017 92
FIG. 65 Canadian Hospital Spending by Type and Function, 2018 (%) 92
FIG. 66 Canada Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 93
FIG. 67 Canada Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 94
FIG. 68 Canada Artificial Iris Market by Application, 2018-2025 (US$ Billion) 94
FIG. 69 Canada Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 95
FIG. 70 Canada Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 95
FIG. 71 Population Aged 65 years or over in Rest of NA, by Country, 2019 & 2030 (%) 96
FIG. 72 GDP of Rest of North American Countries, PPP (2017 & 2019) 97
FIG. 73 Rest of North America Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 97
FIG. 74 Rest of North America Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 98
FIG. 75 Rest of North America Artificial Iris Market by Application, 2018-2025 (US$ Billion) 98
FIG. 76 Rest of North America Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 99
FIG. 77 Rest of North America Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 99
FIG. 78 Europe Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 100
FIG. 79 Europe Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 101
FIG. 80 Europe Artificial Iris Market by Application, 2018-2025 (US$ Billion) 101
FIG. 81 Europe Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 102
FIG. 82 Europe Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 102
FIG. 83 Europe Artificial Iris Market by Country, 2018-2025 (US$ Billion) 103
FIG. 84 Germany Health Spending 104
FIG. 85 Germany Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 104
FIG. 86 Germany Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 105
FIG. 87 Germany Artificial Iris Market by Application, 2018-2025 (US$ Billion) 105
FIG. 88 Germany Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 106
FIG. 89 Germany Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 106
FIG. 90 Population of the Netherlands Recorded Over 65 Years in 2000, 2010, 2019 & 2030 (%) 107
FIG. 91 Netherlands Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 107
FIG. 92 Netherlands Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 108
FIG. 93 Netherlands Artificial Iris Market by Application, 2018-2025 (US$ Billion) 108
FIG. 94 Netherlands Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 109
FIG. 95 Netherlands Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 109
FIG. 96 Rest of Europe Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 110
FIG. 97 Rest of Europe Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 110
FIG. 98 Rest of Europe Artificial Iris Market by Application, 2018-2025 (US$ Billion) 111
FIG. 99 Rest of Europe Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 111
FIG. 100 Rest of Euro Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 112
FIG. 101 Proportion of Total Population Aged 60 or Over In 2016 And 2050 By ESCAP Subregion 113
FIG. 102 Southeast Asia Medical Tourism, 2016 113
FIG. 103 Asia-Pacific Artificial Iris Market by Material Type, 2018-2025 (US$ Billion) 114
FIG. 104 Asia-Pacific Artificial Iris Market by Colour, 2018-2025 (US$ Billion) 114
FIG. 105 Asia-Pacific Artificial Iris Market by Application, 2018-2025 (US$ Billion) 115
FIG. 106 Asia-Pacific Artificial Iris Market by Age Group, 2018-2025 (US$ Billion) 115
FIG. 107 Asia-Pacific Artificial Iris Market by End-User, 2018-2025 (US$ Billion) 116
FIG. 108 Asia Pacific Artificial Iris Market by Country, 2018-2025 (US$ Billion) 116
FIG. 109 Japanese Population Count by Age Group, Current and Forecast 2010-2060 (
Morcher
Ophtec
HumanOptics
Reper NN
VEO Ophthalmics
Spectrum Surgical
EyeYon Medical
Pixium Vision